 |
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 10, 2013
|
11.4 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Bank of America Merrill Lynch 2013 Healthcare Conference to be
held at Encore at the Wynn in Las Vegas on May 15, 2013.
...
|
|
GenMark Diagnostics Reports First Quarter 2013 Results
May 8, 2013
|
24.7 KB |
| |
Quarterly Reagent Revenue Grows Over 463%
Installed Base Grows to 339 Analyzers
Quarterly Gross Margin Reaches 55%
Annuity Per Analyzer Increases to $146,000
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagn...
|
|
GenMark Diagnostics Schedules First Quarter 2013 Financial Results Conference Call for May 8, 2013
Apr 25, 2013
|
9.8 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to
release its first quarter earnings results after market close on
Wednesday, May 8, 2013. Management will hold a conference call to review
the Company's first quarter performance starting at 4:15 p.m. (East...
|
|
GenMark Diagnostics Reports Fourth Quarter and Year End 2012 Results
Mar 12, 2013
|
30.4 KB |
| |
GenMark Exceeds 2012 Revenue Guidance; 2012 Sales Top $20 million
Quarterly Reagent Revenue Grows 404% and Annual Reagent Revenue
Grows 367%
Installed Base Grows to 297 Analyzers
Quarterly Gross Margin Reaches 50% and Annual Gross Margin
...
|
|
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2012 Financial Results and Conference Call for March 12, 2013
Feb 28, 2013
|
9.8 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to
release its fourth quarter and full year 2012 earnings results after
market close on Tuesday, March 12, 2013. Management will hold a
conference call to review the Company's fourth quarter and full year
...
|
|
GenMark Diagnostics to Present at the 31st Annual J.P. Morgan Healthcare Conference
Jan 4, 2013
|
10.4 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the 31st Annual J.P. Morgan Healthcare Conference to be
held at the Westin St. Francis Hotel in San Francisco on January 8,
2013. ...
|
|
GenMark Diagnostics to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 26, 2012
|
11.4 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Canaccord Genuity Medical Technology & Diagnostics Forum to be
held at the Le Parker Meridien in New York, NY on December 4, 2012.
...
|
|
GenMark Diagnostics to Present at the Piper Jaffray 24th Annual Healthcare Conference
Nov 20, 2012
|
11.4 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Piper Jaffray 24th Annual Healthcare Conference to be
held at The New York Palace in New York, NY on November 28, 2012.
...
|
|
GenMark Diagnostics Reports Third Quarter 2012 Results
Nov 7, 2012
|
27.8 KB |
| |
Quarterly Reagent Revenue Grows 339%
Installed Base Grows to 255 Analyzers
Quarterly Gross Margin Reaches 42%
Annuity Per Analyzer Increased to $93,000
FY 2012 Revenue Guidance Raised to >$18 million
...
|
|
GenMark Diagnostics Schedules Third Quarter 2012 Financial Results and Conference Call for November 8, 2012
Oct 26, 2012
|
9.8 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
announced that it plans to release its third quarter 2012 and nine
months ending September 30, 2012 earnings results pre-market on
Thursday, ...
|
|
GenMark to Show its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform at the Association for Molecular Pathology Meeting
Oct 22, 2012
|
11.5 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics Inc., (NASDAQ: GNMK) a leading provider of
automated, multiplex molecular diagnostic testing systems, announced
today that it will show a prototype of the Company's NexGen system, an
all-electronic fully integrated molecular diagnostics platform, at the
...
|
|
GenMark Diagnostics Receives FDA Clearance for RVP Test
Sep 12, 2012
|
10.8 KB |
| |
eSensor® Respiratory Viral Panel Enables Concurrent Detection of
Clinically Relevant Viral Strains, Improves Co-infection Detection,
Distinguishes Rhinovirus from Enteroviruses and Identifies Adenovirus
Species C
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc., (N...
|
|
GenMark Diagnostics to Present at Canaccord Genuity 32nd Annual Growth Conference
Aug 15, 2012
|
10.3 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc., (NASDAQ:GNMK) a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the Canaccord Genuity 32nd Annual Growth Conference to be held at the
InterContinental Boston hotel in Boston, Massachusetts today.
...
|
|
GenMark Diagnostics Reports Second Quarter 2012 Results
Aug 7, 2012
|
27.4 KB |
| |
Quarterly Reagent Revenue Grows Over 300%
Installed Base Grows to 220 Analyzers
Quarterly Gross Margin Reaches 40%
Annuity Per Analyzer $73,000
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (...
|
|
GenMark Diagnostics Schedules Second Quarter 2012 Financial Results and Conference Call for August 7, 2012
Aug 2, 2012
|
9.9 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to
release its second quarter 2012 earnings results after market close on
Tuesday, August 7, 2012. Management will hold a conference call to
review the Company's Second quarter and First half 2012 performance...
|
|
GenMark Diagnostics and Advanced Liquid Logic Finalize Technology and Collaboration Agreements to Develop an All-Digital Fully Integrated Diagnostic Platform
Jul 31, 2012
|
11.1 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc., (NASDAQ: GNMK) and Advanced Liquid Logic,
Inc. (ALL) announced today that they have executed definitive agreements
pursuant to which GenMark and ALL will collaborate to develop an
all-digital, fully integrated in-vitro diagnostic platform bringing
...
|
|
GenMark Diagnostics Prices Public Offering of Common Stock
Jun 20, 2012
|
13.4 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK),
today announced the pricing of an underwritten public offering of
10,000,000 shares of its common stock at a public offering price of
$4.20 per share. All of the shares in the offering are being sold by
GenMark. The offering is...
|
|
GenMark Diagnostics Announces Proposed Public Offering of Common Stock
Jun 19, 2012
|
13.3 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK),
a provider of automated, multiplex molecular diagnostic testing systems,
announced today that it intends to commence an underwritten public
offering of 10,000,000 shares of its common stock. All of the shares in
the proposed of...
|
|
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Jun 14, 2012
|
12.3 KB |
| |
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK),
a provider of automated, multiplex molecular diagnostic testing systems,
announced today that Dr. Stephen T. Worland has been appointed to
GenMark's Board of Directors.
Stephen Worland has extensive experience i...
|
|
GenMark Diagnostics Increases 2012 Revenue Guidance
Jun 12, 2012
|
10.6 KB |
| |
Reagents Revenue Accelerates
CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (Nasdaq:GNMK) today provided revised
revenue estimates for the second quarter ending June 30, 2012 and for
the calendar year ending December 31, 2012. Based on year-to-date
performance and rev...
|
|
|
